Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $51.02 $63.08 Friday, 10th May 2024 CRSP stock ended at $51.17. This is 4.44% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 7.59% from a day low at $51.02 to a day high of $54.89.
90 days $51.02 $91.10
52 weeks $37.55 $91.10

Historical CRISPR Therapeutics AG prices

Date Open High Low Close Volume
Dec 15, 2023 $63.47 $64.28 $61.55 $62.08 2 574 720
Dec 14, 2023 $62.84 $63.90 $59.86 $62.94 3 449 269
Dec 13, 2023 $57.70 $61.44 $55.21 $61.43 4 467 105
Dec 12, 2023 $60.51 $60.70 $57.58 $58.12 3 640 288
Dec 11, 2023 $62.95 $63.00 $56.08 $60.28 8 750 338
Dec 08, 2023 $71.07 $76.97 $61.55 $64.54 17 132 757
Dec 07, 2023 $70.74 $71.00 $69.09 $70.21 2 108 663
Dec 06, 2023 $71.45 $74.39 $70.06 $71.14 2 446 946
Dec 05, 2023 $70.65 $72.69 $68.30 $70.60 1 850 626
Dec 04, 2023 $69.10 $72.97 $68.56 $71.51 2 772 127
Dec 01, 2023 $66.22 $68.70 $63.39 $68.65 3 359 767
Nov 30, 2023 $70.49 $71.18 $66.51 $66.73 2 503 544
Nov 29, 2023 $71.38 $73.55 $68.93 $69.09 2 194 641
Nov 28, 2023 $71.17 $71.74 $69.44 $70.66 1 845 466
Nov 27, 2023 $69.75 $71.85 $67.82 $71.61 2 130 339
Nov 24, 2023 $70.49 $73.40 $69.65 $69.97 1 880 486
Nov 22, 2023 $68.69 $71.18 $68.00 $70.49 2 552 545
Nov 21, 2023 $71.44 $71.67 $67.18 $67.57 3 921 310
Nov 20, 2023 $69.57 $76.19 $68.10 $72.18 7 986 814
Nov 17, 2023 $61.18 $68.94 $60.80 $67.89 6 456 942
Nov 16, 2023 $58.06 $60.41 $55.76 $59.22 3 348 221
Nov 15, 2023 $55.68 $57.10 $54.34 $56.23 1 787 961
Nov 14, 2023 $55.38 $56.79 $53.60 $55.30 1 989 298
Nov 13, 2023 $52.03 $52.42 $48.55 $52.01 2 843 680
Nov 10, 2023 $51.42 $53.61 $49.54 $53.16 2 252 816
Click to get the best stock tips daily for free!

About CRISPR Therapeutics AG

CRISPR Therapeutics CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA. The company has a portfolio of therapeutic programs across a range of disease areas, including hemoglo... CRSP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT